Acadian Asset Management LLC raised its holdings in Zoetis Inc (NYSE:ZTS) by 111.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,709,352 shares of the company’s stock after purchasing an additional 900,261 shares during the quarter. Acadian Asset Management LLC owned 0.35% of Zoetis worth $123,143,000 as of its most recent SEC filing.
Other hedge funds have also modified their holdings of the company. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Zoetis by 16.8% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,598 shares of the company’s stock valued at $100,000 after purchasing an additional 230 shares in the last quarter. Steward Partners Investment Advisory LLC acquired a new stake in shares of Zoetis in the 3rd quarter valued at $114,000. Harfst & Associates Inc. boosted its holdings in shares of Zoetis by 16.1% in the 2nd quarter. Harfst & Associates Inc. now owns 1,878 shares of the company’s stock valued at $117,000 after purchasing an additional 260 shares in the last quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its holdings in shares of Zoetis by 251.9% in the 3rd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 1,900 shares of the company’s stock valued at $121,000 after purchasing an additional 1,360 shares in the last quarter. Finally, Shine Investment Advisory Services Inc. boosted its holdings in shares of Zoetis by 86.5% in the 3rd quarter. Shine Investment Advisory Services Inc. now owns 2,242 shares of the company’s stock valued at $143,000 after purchasing an additional 1,040 shares in the last quarter. 93.14% of the stock is currently owned by hedge funds and other institutional investors.
A number of brokerages have weighed in on ZTS. Piper Jaffray Companies raised their target price on Zoetis to $86.00 and gave the company an “outperform” rating in a report on Thursday. Cantor Fitzgerald set a $85.00 target price on Zoetis and gave the company a “buy” rating in a report on Thursday, January 11th. Citigroup raised Zoetis from a “neutral” rating to a “buy” rating and set a $85.00 target price on the stock in a report on Thursday, January 4th. BMO Capital Markets reiterated a “hold” rating on shares of Zoetis in a research note on Monday, January 8th. Finally, BidaskClub cut Zoetis from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, September 20th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and fourteen have given a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $73.72.
Shares of Zoetis Inc (NYSE:ZTS) traded up $1.23 on Thursday, hitting $76.77. The stock had a trading volume of 2,769,500 shares, compared to its average volume of 2,426,191. Zoetis Inc has a one year low of $52.00 and a one year high of $77.03. The company has a market cap of $37,140.00, a PE ratio of 40.41, a price-to-earnings-growth ratio of 1.88 and a beta of 1.06. The company has a quick ratio of 1.95, a current ratio of 2.80 and a debt-to-equity ratio of 2.45.
Zoetis (NYSE:ZTS) last announced its quarterly earnings results on Thursday, November 2nd. The company reported $0.65 EPS for the quarter, beating the Zacks’ consensus estimate of $0.63 by $0.02. The company had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.32 billion. Zoetis had a return on equity of 62.39% and a net margin of 18.29%. Zoetis’s revenue was up 8.5% compared to the same quarter last year. During the same period in the prior year, the company earned $0.52 EPS. research analysts anticipate that Zoetis Inc will post 2.37 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Thursday, March 1st. Investors of record on Friday, January 19th will be given a dividend of $0.126 per share. This is a positive change from Zoetis’s previous quarterly dividend of $0.11. This represents a $0.50 annualized dividend and a yield of 0.66%. The ex-dividend date of this dividend is Thursday, January 18th. Zoetis’s dividend payout ratio (DPR) is currently 22.11%.
ILLEGAL ACTIVITY WARNING: This story was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this story on another site, it was illegally copied and reposted in violation of U.S. & international copyright law. The correct version of this story can be read at https://www.dispatchtribunal.com/2018/01/18/zoetis-inc-zts-shares-bought-by-acadian-asset-management-llc.html.
Zoetis Company Profile
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.